GZMB anticorps (C-Term)
Aperçu rapide pour GZMB anticorps (C-Term) (ABIN2276833)
Antigène
Voir toutes GZMB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- Granzyme B, CT (GRB, GZMB, C11, Cathespin G-like 1, CCPI, CGL1, CGL-1, CSPB, CSP-B, CTLA1, CTLA-1, CTSGL1, Cytotoxic T Lymphocyte-associated Serine Esterase 1, Cytotoxic T Lymphocyte Proteinase 2, Fragmentin 2, Fragmentin-2, Granzyme 2, Human Lymphocyte Protein, HLP, Lymphocyte Protease, Protease Serine B, SECT, T-cell Serine Protease 1-3E)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogène
- Synthetic peptide selected from the C-terminal region of human GZMB (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- GZMB (Granzyme B (GZMB))
-
Autre désignation
- Granzyme B
-
NCBI Accession
- NP_004122
-
UniProt
- P10144
-
Pathways
- Apoptose, Caspase Cascade in Apoptosis
Antigène
-